{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:36:57Z","timestamp":1786736217605,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijpm.ijpm_134_19","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T09:19:31Z","timestamp":1567156771000},"page":"384","source":"Crossref","is-referenced-by-count":11,"title":["Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study"],"prefix":"10.4103","volume":"62","author":[{"given":"AnandNarain","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishi","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumana","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.263465-1","first-page":"740","volume-title":"Geographic pathology revisited: Development of an atlas of cancer in India","author":"Nandakumar","year":"2005","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0377-4929.263465-2","unstructured":"National Cancer Registry Programme, Indian Council of Medical Research: Three Year Report of Population Based Cancer Registries; 2009-2011. ICMR, Three Year Report of the PBCRs: 2006-2008; 2008."},{"key":"key-10.4103\/0377-4929.263465-3","first-page":"228","volume-title":"Characteristics of gallbladder cancer in South India","author":"Sachidananda","year":"2012","journal-title":"Indian J Surg Oncol"},{"key":"key-10.4103\/0377-4929.263465-4","first-page":"196","volume-title":"Post-operative adjuvant treatment in carcinoma gall bladder: A brief review","author":"Singh","year":"2014","journal-title":"Clin Cancer Investig J","ISSN":"https:\/\/id.crossref.org\/issn\/2278-0513","issn-type":"print"},{"key":"key-10.4103\/0377-4929.263465-5","first-page":"245","volume-title":"The inflammatory inception of gallbladder cancer","author":"Espinoza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0377-4929.263465-6","first-page":"12211","volume-title":"Gallbladder carcinoma: Prognostic factors and therapeutic options","author":"Goetze","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0377-4929.263465-7","first-page":"S20","volume-title":"Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/0377-4929.263465-8","unstructured":"Zeineddine D, Hammoud A, Mortada M, Boeu H. The Oct4 protein: More than a magic stemness marker. Am J Stem Cells 2014;3:74-82."},{"key":"key-10.4103\/0377-4929.263465-9","first-page":"1107","volume-title":"Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma","author":"Zhao","year":"2011","journal-title":"Cancer Sci"},{"key":"key-10.4103\/0377-4929.263465-10","first-page":"1389","volume-title":"CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer","author":"Maeda","year":"2008","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0377-4929.263465-11","first-page":"535","volume-title":"Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry","author":"Wu","year":"2012","journal-title":"BMC Cancer"},{"key":"key-10.4103\/0377-4929.263465-12","first-page":"1201","volume-title":"Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients","author":"Takahashi","year":"2010","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0377-4929.263465-13","first-page":"1471","volume-title":"The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key-10.4103\/0377-4929.263465-14","first-page":"364","volume-title":"Aprotein interaction network for pluripotency of embryonic stem cells","author":"Wang","year":"2006","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.263465-15","first-page":"196","volume-title":"Expression of cancer stem cell markers OCT4 and CD133 in transitional cell carcinomas","author":"Sedaghat","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key-10.4103\/0377-4929.263465-16","first-page":"15","volume-title":"Clinical significance of Aldh1a1, Cd133 and Oct 4 in breast cancer and its association with epithelial mesenchymal transition","author":"Joshi","year":"2018","journal-title":"J Genet Mutat"},{"key":"key-10.4103\/0377-4929.263465-17","first-page":"461","volume-title":"The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B","author":"Gao","year":"2010","journal-title":"J Genet Genomics"},{"key":"key-10.4103\/0377-4929.263465-18","first-page":"e0118033","volume-title":"The differential expression of OCT4 isoforms in cervical carcinoma","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0377-4929.263465-19","first-page":"648420","volume-title":"PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: Implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma","author":"Zou","year":"2013","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0377-4929.263465-20","first-page":"3618","volume-title":"Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance","author":"Zhang","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"key-10.4103\/0377-4929.263465-21","first-page":"274","volume-title":"Merkel cell carcinoma exhibiting cytoplasmic OCT4 staining: A potential new diagnostic immunohistochemical marker","author":"Kao","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"key-10.4103\/0377-4929.263465-22","first-page":"11739","volume-title":"Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas","author":"Rasti","year":"2018","journal-title":"Sci Rep"},{"key":"key-10.4103\/0377-4929.263465-23","first-page":"1313","volume-title":"High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection","author":"Zhang","year":"2019","journal-title":"J Cancer"},{"key":"key-10.4103\/0377-4929.263465-24","first-page":"7663","volume-title":"Expression of Sox 2 and Oct4 and their clinical significance in human non-small-cell lung cancer","author":"Li","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key-10.4103\/0377-4929.263465-25","first-page":"e2637","volume-title":"Oct-4 Expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"key-10.4103\/0377-4929.263465-26","first-page":"1","volume-title":"Diagnostic values of a progenitor cell marker CD133 expression in various types of adenocarcinoma","author":"Zhang","year":"2016","journal-title":"J Mol Biomark Diagn"},{"key":"key-10.4103\/0377-4929.263465-27","first-page":"2965","volume-title":"CD133+ gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity","author":"Shi","year":"2011","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0377-4929.263465-28","first-page":"84","volume-title":"Expression of the cancer stem cell markers CD44 and CD133 in colorectal cancer: An immunohistochemical staining analysis","author":"Hong","year":"2015","journal-title":"Ann Coloproctol"},{"key":"key-10.4103\/0377-4929.263465-29","first-page":"1149","volume-title":"Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis","author":"Arne","year":"2011","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0377-4929.263465-30","first-page":"1154","volume-title":"Evaluating the expression of Oct4 as a prognostic tumor marker in bladder cancer","author":"Hatefi","year":"2012","journal-title":"Iran J Basic Med Sci"},{"key":"key-10.4103\/0377-4929.263465-31","first-page":"325","volume-title":"Expression of stem cell markers Cd133 and Oct4 in rectosigmoid adenocarcinoma and their predictive significance of response to chemotherapy and\\or radiotherapy","author":"Abdel-Hadi","year":"2018","journal-title":"J Carcinog Mutagen"},{"key":"key-10.4103\/0377-4929.263465-32","first-page":"6423","volume-title":"Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer","author":"Mizukami","year":"2018","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0377-4929.263465-33","first-page":"574","volume-title":"Prognostic value of the stem cell markers Epcam and CD133 expression of gallbladder adenocarcinoma","author":"Jiang","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"key-10.4103\/0377-4929.263465-34","first-page":"1192","volume-title":"Strong expression of CD133 is associated with increased cholangiocarcinoma progression","author":"Leelawat","year":"2011","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0377-4929.263465-35","first-page":"507","volume-title":"Expression and prognostic value of tumor stem cell markers ALDH1 and CD 133 in colorectal carcinoma","author":"Zhou","year":"2014","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0377-4929.263465-36","first-page":"1211","volume-title":"Increased expression of CD 133 is a strong predictor of poor outcome in stage I colorectal cancer patients","author":"Bonetti","year":"2012","journal-title":"Scand J Gastroenterol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:02Z","timestamp":1786732742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_134_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["263465"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_134_19","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}